NAMS Price Chart
Loading chart...
50 DMA150 DMA200 DMA
NAMSNewAmsterdam Pharma Company N.V.
$31.83
Financials
AVOID
Investment Thesis
NAMS has middling strength (RS 77/99) and declining earnings. Wait for fundamental turnaround. Smart traders skip this one until the setup improves.
Below-average RS + negative growth = No edge
Key Takeaways
- Earnings weak
- RS 77 - needs improvement
- No base pattern
- Wait & watch
Earnings Momentum
Earnings Declining
Price Structure
Partial AlignmentPrice
$31.83
→
50 DMA
$36.35
✓→
100 DMA
$33.39
✓→
150 DMA
$29.51
✓→
200 DMA
$26.66
Alignment Score: 3/4
LEADERSHIP TEST FAILED
Declining/weak EPS with RS < 80. Need either 80+ RS OR super-performer earnings.
Why Not BUY Yet?
RS Rating
77 (Top 23%)→>80 (Top 20%)
EPS Growth
-239%→>25% Qtr YoY
Pattern
No base forming→VCP or constructive base
Entry Point
Broke out 5mo ago, now +26%→Wait for pullback or new base
What Would Change Our Mind?
To turn bullish on NAMS, we need:
- RS Rating: >80 (Top 20%)(currently 77 (Top 23%))
- EPS Growth: >25% Qtr YoY(currently -239%)
- Pattern: VCP or constructive base(currently No base forming)
- Entry Point: Wait for pullback or new base(currently Broke out 5mo ago, now +26%)
- Fresh Entry: Pullback to 50 DMA or new base formation(currently Extended +26% from 5mo ago breakout)
Twin Engines Dashboard
Technical Health
RS Rating
77/99
Top 23% (Need 80+)
Trend
Uptrend
Above 200 DMA
RSI (14)
36
WEAK
VCP Setup
COOL
Score: 4/9
Volume
1.4M
+47% vs avg
From Entry
+25.8%
$25.31
Fundamental Horsepower
EPS Qtr YoY
-239%
Declining
EPS 3Y CAGR
N/A
Annual Earnings
Revenue Qtr
-99%
DECLINING
F-Score
4/9
Piotroski Quality
ROE
-46%
Return on Equity
EPS Rank
43/99
Percentile
Trade Plan
Lost MomentumBreakout Date2025-08-08161 days ago
Entry Was$25.31Breakout price
Gain Since+26%From entry
Reclaim$34.2921 EMA support
If/Then Playbook
IF: EPS growth turns positive next quarter
THEN: Reassess with fresh eyes
IF: RS Rating improves to >85
THEN: Consider for WATCHLIST if EPS improves
Key Price Levels
Resistance
- 20 DMA$34.38+8.0%
- 50 DMA$36.35+14.2%
- 52W High$42.00+32.0%
Current$31.83
Support
- 200 DMA$26.66-16.2%
- 52W Low$14.06-55.8%
More NAMS Analysis
Frequently Asked Questions
Is NAMS stock a buy now?
NAMS has middling strength (RS 77/99) and declining earnings. Wait for fundamental turnaround. Smart traders skip this one until the setup improves.
What is the buy point for NAMS?
NAMS broke out at $25.31 5 month(s) ago and is now +26% extended. Wait for a pullback to the 21 EMA or a new base pattern.
What is NAMS's RS Rating?
NAMS has an RS Rating of 77/99, meaning it's in the Top 23% of all stocks for relative price performance over the past 12 months. Minervini recommends RS 80+ for momentum trades.
Important Disclosure: This analysis is for educational and informational purposes only. Technical and fundamental indicators are based on historical data and do not guarantee future performance. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.